Examining the Neural Mechanisms of RTMS: a Naturalistic Pilot Study of Acute and Serial Effects in Pharmacoresistant Depression

Overview

Journal Front Neural Circuits

Date 2023 May 19

PMID 37206978

Authors

Camila Cosmo

Amin Zandvakili

Nicholas J Petrosino

Thaise Graziele L de O Toutain

Jose Garcia Vivas Miranda

Noah S Philip

Affiliations

Soon will be listed here.

Abstract

Introduction: Previous studies have demonstrated the effectiveness of therapeutic repetitive transcranial magnetic stimulation (rTMS) to treat pharmacoresistant depression. Nevertheless, these trials have primarily focused on the therapeutic and neurophysiological effects of rTMS following a long-term treatment course. Identifying brain-based biomarkers of early rTMS therapeutic response remains an important unanswered question. In this pilot study, we examined the effects of rTMS on individuals with pharmacoresistant depression using a graph-based method, called Functional Cortical Networks (FCN), and serial electroencephalography (EEG). We hypothesized that changes in brain activity would occur early in treatment course.

Methods: A total of 15 patients with pharmacoresistant depression underwent five rTMS sessions (5Hz over the left dorsolateral prefrontal cortex, 120%MT, up to 4,000 pulses/session). Five participants received additional rTMS treatment, up to 40 sessions. Resting EEG activity was measured at baseline and following every five sessions, using 64-channel EEG, for 10 minutes with eyes closed. An FCN model was constructed using time-varying graphs and motif synchronization. The primary outcome was acute changes in weighted-node degree. Secondary outcomes included serial FFT-based power spectral analysis and changes in depressive symptoms measured by the 9-Item Patient Health Questionnaire (PHQ-9) and the 30-item Inventory of Depressive Symptoms-Self Report (IDS-SR).

Results: We found a significant acute effect over the left posterior area after five sessions, as evidenced by an increase in weighted-node degree of 37,824.59 (95% CI, 468.20 to 75,180.98) and a marginal enhancement in the left frontal region (t (14) = 2.0820, = 0.056). One-way repeated measures ANOVA indicated a significant decrease in absolute beta power over the left prefrontal cortex (F (7, 28) = 2.37, = 0.048) following ten rTMS sessions. Furthermore, a significant clinical improvement was observed following five rTMS sessions on both PHQ-9 (t (14) = 2.7093, = 0.017) and IDS-SR (t (14) = 2.5278, = 0.024) and progressed along the treatment course.

Discussion: Our findings suggest that FCN models and serial EEG may contribute to a deeper understanding of mechanisms underlying rTMS treatment. Additional research is required to investigate the acute and serial effects of rTMS in pharmacoresistant depression and assess whether early EEG changes could serve as predictors of therapeutic rTMS response.

References

Machado L, Cantilino A . A systematic review of the neural correlates of positive emotions. Braz J Psychiatry. 2016; 39(2):172-179. PMC: 7111451. DOI: 10.1590/1516-4446-2016-1988. View

McIntyre R, Filteau M, Martin L, Patry S, Carvalho A, Cha D . Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2013; 156:1-7. DOI: 10.1016/j.jad.2013.10.043. View

Carpenter L, Janicak P, Aaronson S, Boyadjis T, Brock D, Cook I . Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012; 29(7):587-96. DOI: 10.1002/da.21969. View

Philip N, Carpenter S, Ridout S, Sanchez G, Albright S, Tyrka A . 5Hz Repetitive transcranial magnetic stimulation to left prefrontal cortex for major depression. J Affect Disord. 2015; 186:13-7. PMC: 4565741. DOI: 10.1016/j.jad.2014.12.024. View

Zhdanava M, Pilon D, Ghelerter I, Chow W, Joshi K, Lefebvre P . The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States. J Clin Psychiatry. 2021; 82(2). DOI: 10.4088/JCP.20m13699. View

Paquette V, Beauregard M, Beaulieu-Prevost D . Effect of a psychoneurotherapy on brain electromagnetic tomography in individuals with major depressive disorder. Psychiatry Res. 2009; 174(3):231-9. DOI: 10.1016/j.pscychresns.2009.06.002. View

Valiulis V, Gerulskis G, Dapsys K, Vistartaite G, Siurkute A, Maciulis V . Electrophysiological differences between high and low frequency rTMS protocols in depression treatment. Acta Neurobiol Exp (Wars). 2012; 72(3):283-95. DOI: 10.55782/ane-2012-1901. View

Benadhira R, Thomas F, Bouaziz N, Braha S, Schenin-King Andrianisaina P, Isaac C . A randomized, sham-controlled study of maintenance rTMS for treatment-resistant depression (TRD). Psychiatry Res. 2017; 258:226-233. DOI: 10.1016/j.psychres.2017.08.029. View

Cosmo C, Zandvakili A, Petrosino N, Berlow Y, Philip N . Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Recent Critical Advances in Patient Care. Curr Treat Options Psychiatry. 2021; 8(2):47-63. PMC: 7946620. DOI: 10.1007/s40501-021-00238-y. View

10.

Demitrack M, Thase M . Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharmacol Bull. 2009; 42(2):5-38. View

11.

Alyagon U, Shahar H, Hadar A, Barnea-Ygael N, Lazarovits A, Shalev H . Alleviation of ADHD symptoms by non-invasive right prefrontal stimulation is correlated with EEG activity. Neuroimage Clin. 2020; 26:102206. PMC: 7021642. DOI: 10.1016/j.nicl.2020.102206. View

12.

Cardenas V, Bhat J, Horwege A, Ehrlich T, Lavacot J, Mathalon D . Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression. Brain Stimul. 2021; 15(1):63-72. PMC: 8900427. DOI: 10.1016/j.brs.2021.11.008. View

13.

Spronk D, Arns M, Bootsma A, van Ruth R, Fitzgerald P . Long-term effects of left frontal rTMS on EEG and ERPs in patients with depression. Clin EEG Neurosci. 2008; 39(3):118-24. DOI: 10.1177/155005940803900305. View

14.

Muller V, Cieslik E, Laird A, Fox P, Eickhoff S . Dysregulated left inferior parietal activity in schizophrenia and depression: functional connectivity and characterization. Front Hum Neurosci. 2013; 7:268. PMC: 3679482. DOI: 10.3389/fnhum.2013.00268. View

15.

Palmiero M, Piccardi L . Frontal EEG Asymmetry of Mood: A Mini-Review. Front Behav Neurosci. 2017; 11:224. PMC: 5701669. DOI: 10.3389/fnbeh.2017.00224. View

16.

Henriques J, Davidson R . Left frontal hypoactivation in depression. J Abnorm Psychol. 1991; 100(4):535-45. DOI: 10.1037//0021-843x.100.4.535. View

17.

Numssen O, Bzdok D, Hartwigsen G . Functional specialization within the inferior parietal lobes across cognitive domains. Elife. 2021; 10. PMC: 7946436. DOI: 10.7554/eLife.63591. View

18.

Liston C, Chen A, Zebley B, Drysdale A, Gordon R, Leuchter B . Default mode network mechanisms of transcranial magnetic stimulation in depression. Biol Psychiatry. 2014; 76(7):517-26. PMC: 4209727. DOI: 10.1016/j.biopsych.2014.01.023. View

19.

Ochsner K, Bunge S, Gross J, Gabrieli J . Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J Cogn Neurosci. 2002; 14(8):1215-29. DOI: 10.1162/089892902760807212. View

20.

Melnikov M, Petrovskii E, Bezmaternykh D, Kozlova L, Shtark M, Savelov A . fMRI Response of Parietal Brain Areas to Sad Facial Stimuli in Mild Depression. Bull Exp Biol Med. 2018; 165(6):741-745. DOI: 10.1007/s10517-018-4255-y. View